GPT Healthcare Board Approves FY26 Results, Recommends ₹1.50 Dividend

GPT Healthcare Ltd's Board of Directors met on May 18, 2026, approving the Audited Financial Results for the fourth quarter and full financial year ended March 31, 2026, with an un-modified audit opinion. The Board recommended a final dividend of ₹1.50 per equity share (15%) for FY26, pending shareholder approval at the 37th Annual General Meeting (AGM) scheduled for August 6, 2026. The record date for dividend entitlement is set for July 30, 2026. Additionally, the Board approved the reappointment of statutory, cost, and internal auditors for FY26-27, re-appointed two independent directors, and approved the continuation of another independent director past 75 years of age. Increases in remuneration for two relatives of directors and consultancy fees for a non-executive director were also approved.